Delivery Order SPE2DB24D2101-SPE2DB25FKPTH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,168.50 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) on April 9, 2025, with an ultimate completion date of April 10, 2025. This firm fixed-price delivery order was not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is performed at the awardee's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.30 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price, competitively awarded contract represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a $1,730.46 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Carvedilol ER 10 mg capsules in a 30-count quantity. This firm fixed-price contract represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract with a ceiling value of $11,565.51. The award was made on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, with performance occurring at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.65 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,338.24 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units). This firm fixed price delivery order was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was competitively awarded without set-aside designation and represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract valued at $1,358.25. The order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical procurement, with performance occurring at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $12,904.18 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed price contract type. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive, non-set-aside procurement executed through the company's existing contract vehicle. Performance will take place at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPTHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,637.17 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation, indicating open competition among qualified vendors. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through this vehicle, supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 9/18/25 |